Menu

Michal Berkner

Partner

+44 (0) 20 7556 4321
mberkner@cooley.com

Michal Berkner leads cross-border mergers and acquisitions, advising tech and life sciences companies in game-changing M&A, including SPACs, reverse mergers, negotiated and unsolicited transactions and joint ventures. Her clients include strategic and private equity buyers and sellers in public and private transactions. She is dual qualified in New York and England & Wales.

Download full bio 

Experience

  • Brandwatch Agrees to Sell to Cision for $450 Million 

  • Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab 

  • DocuSign to Acquire AI Technology Provider Seal Software 

  • Therachon Sells to Pfizer for up to $810 Million 

Practices & Industries
Education

  • University of Pennsylvania Law School
    JD, 1997

  • Johns Hopkins University
    BA, 1994

Admissions & Credentials

England & Wales

New York

Media & Insight

Recent Blog Postings

Renegotiating Deal Terms? Delaware Reminds Fiduciaries of Unremitting Duties

Social Distancing From a (Supposed) Life Partner: Early Lessons From Deals Terminated and On the Rocks in the COVID-19 Era

Long-Term Focus: Preparing for Activism + Takeovers Amid COVID-19 Risks

Cooley’s 2019 Tech M&A Year in Review

Cooley's 2019 Life Sciences M&A Year in Review

Taking a Play out of the Financial Acquirer’s Playbook

Use of Earn-Outs to “Bridge” the Valuation Gap

 

 

contact

+44 (0) 20 7556 4321 office
mberkner@cooley.com

22 Bishopsgate
London, UK EC2N 4BQ